Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.
Perifanis
Vasilios
V
Vyzantiadis
Timos
T
Vakalopoulou
Sofia
S
Tziomalos
Konstantinos
K
Garypidou
Vasilia
V
Athanassiou-Metaxa
Miranta
M
Harsoulis
Fedon
F
D000328:Adult; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D000077211:Zoledronic Acid; D017086:beta-Thalassemia / Q000150:complications*
D004164:Diphosphonates; D007093:Imidazoles; D007334:Insulin-Like Growth Factor I; D000077211:Zoledronic Acid